This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Jeremy D. Young, MD, MPH
Advertisement
Articles by Jeremy D. Young, MD, MPH
Advertisement
Latest Updated Articles
New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 InfectionPublished: June 10th 2016 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Prospective Game Changer: Lenacapavir for HIV Preexposure Prophylaxis
2
Unlocking New Defenses: The Changing Landscape of Candida auris Management
3
COVID-19: The Gaps in Science Communication
4
Top Infectious Disease News Stories Week of January 3 - January 9
5